Application 208038
- Type
- ANDA
- Sponsor
- US GENERICS, STERILES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHYLNALTREXONE BROMIDE | METHYLNALTREXONE BROMIDE | SOLUTION;SUBCUTANEOUS | 12MG/0.6ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Relistor | METHYLNALTREXONE BROMIDE | Salix Pharmaceuticals, Inc. | c488fb7c-0a5b-487c-b452-996809d1cb99 | 2024-05-01 | Warnings, Adverse reactions | METHYLNALTREXONE BROMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 68529 | ORIG | 2021-09-02 |